DK0486609T3 - Farmaceutisk produkt til behandling af sepsis - Google Patents

Farmaceutisk produkt til behandling af sepsis

Info

Publication number
DK0486609T3
DK0486609T3 DK90913206.0T DK90913206T DK0486609T3 DK 0486609 T3 DK0486609 T3 DK 0486609T3 DK 90913206 T DK90913206 T DK 90913206T DK 0486609 T3 DK0486609 T3 DK 0486609T3
Authority
DK
Denmark
Prior art keywords
antibody
sepsis
specific
treatment
lps
Prior art date
Application number
DK90913206.0T
Other languages
English (en)
Inventor
Mark William Bodmer
Steven Michael Opal
Alan S Cross
Jerald Sadoff
Original Assignee
Celltech Ltd
Mark William Bodmer
Steven Michael Opal
Alan S Cross
Sadoff Jerald C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Ltd, Mark William Bodmer, Steven Michael Opal, Alan S Cross, Sadoff Jerald C filed Critical Celltech Ltd
Application granted granted Critical
Publication of DK0486609T3 publication Critical patent/DK0486609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK90913206.0T 1989-08-10 1990-08-10 Farmaceutisk produkt til behandling af sepsis DK0486609T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918232A GB8918232D0 (en) 1989-08-10 1989-08-10 Pharmaceutical product for the treatment of septic shock

Publications (1)

Publication Number Publication Date
DK0486609T3 true DK0486609T3 (da) 1995-05-08

Family

ID=10661418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90913206.0T DK0486609T3 (da) 1989-08-10 1990-08-10 Farmaceutisk produkt til behandling af sepsis

Country Status (10)

Country Link
EP (1) EP0486609B1 (da)
JP (1) JPH05505592A (da)
AT (1) ATE119043T1 (da)
AU (2) AU651320B2 (da)
DE (1) DE69017455T2 (da)
DK (1) DK0486609T3 (da)
ES (1) ES2071827T3 (da)
GB (2) GB8918232D0 (da)
WO (1) WO1991001755A1 (da)
ZA (1) ZA906345B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138662T3 (es) * 1993-06-03 2000-01-16 Therapeutic Antibodies Inc Produccion de fragmentos de anticuerpos.
AU7194894A (en) * 1993-07-20 1995-02-20 Sumio Arai Endotoxin neutralizer
AU2356095A (en) * 1994-04-20 1995-11-29 U.S. Department Of The Army Vaccine against gram-negative bacterial infections
US6858211B1 (en) * 1998-07-20 2005-02-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccines against Escherichia coli O157 infection
DE19913707A1 (de) * 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
EP1348443A4 (en) * 2000-12-08 2005-07-06 Takeda Pharmaceutical COMBINED MEDICINES
EP1819731A4 (en) 2004-12-08 2013-02-13 Immunomedics Inc METHOD AND COMPOSITION FOR IMMUNOTHERAPY AND FOR THE DETECTION OF INFLAMMATORY AND DYSEGRATIVE IMMUNE DISEASES, INFECTION DISEASES, PATHOLOGICAL ANGIOGENESIS AND CANCER

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
NZ229922A (en) * 1988-07-18 1992-04-28 Chiron Corp Monoclonal antibodies specifically binding cachectin (tumor necrosis factor) and compositions
EP0355067A1 (en) * 1988-08-19 1990-02-21 Celltech Limited Pharmaceutical products for anti-neoplastic therapy
SG43205A1 (en) * 1988-12-19 1997-10-17 American Cyanamid Co A method for the treatment of endotoxic shock in a mammal

Also Published As

Publication number Publication date
EP0486609B1 (en) 1995-03-01
ZA906345B (en) 1992-04-29
GB8918232D0 (en) 1989-09-20
ATE119043T1 (de) 1995-03-15
DE69017455T2 (de) 1995-06-29
EP0486609A1 (en) 1992-05-27
AU7590694A (en) 1995-01-27
GB2251187A (en) 1992-07-01
DE69017455D1 (de) 1995-04-06
GB2251187B (en) 1993-06-23
GB9202615D0 (en) 1992-03-25
AU6350090A (en) 1991-03-11
ES2071827T3 (es) 1995-07-01
JPH05505592A (ja) 1993-08-19
AU651320B2 (en) 1994-07-21
WO1991001755A1 (en) 1991-02-21

Similar Documents

Publication Publication Date Title
NO901679D0 (no) Fremgangsmaate for fremstilling av et produkt analogt til glassaalen og produktet oppnaadd paa den maaten.
ES2066603T3 (es) Fungicidas de 3-difluorometilpirazolcarboxamida.
EA199800946A1 (ru) Концентрированный препарат антител
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO953710D0 (no) Rehydrert produkt og fremgangsmåte for fremstilling derav
ATE195875T1 (de) Spezifische modulationen des immunsystems
DK0486609T3 (da) Farmaceutisk produkt til behandling af sepsis
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DE69434384D1 (de) Metalkomplexbildner
DK159114C (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
ES2111000T3 (es) Separacion de proteinas y colorantes.
AU525403B2 (en) Purified antigen
BR0015287A (pt) Moléculas recombinantes de fusão
NO913817L (no) Fremgangsmaate og produkt for tekstilfarging.
DE69028094T2 (de) Konjugate von antikörpern mit variablen domänen
NO913078L (no) Oekt proteinproduksjon i dyr.
NO890965D0 (no) Superledende produkt og fremgangsmaate for dets fremstilling.
PT100566A (pt) Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso
DK176290D0 (da) Terapeutisk og diagnostisk praeparat
MX9101578A (es) Proceso para reducir el contenido de compuestos poliaromaticos en liquidos
ATE125306T1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
DK0448412T3 (da) Fremgangsmåde til fremstilling af glycaler i allal- og gulalserierne
BG51731A1 (en) Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome